Abstract:Platelet‐derived growth factor (PDGF), is one of the major growth factors found in mammalian serum, which plays an important role in cell growth. It has been previously demonstrated that abnormal activation of the PDGF signaling pathway can contribute to aberrant pulmonary vascular remodeling and pulmonary hypertension via active PDGF receptors. The overall goal of this study was to examine the expression of the PDGFR isoforms in both pulmonary artery smooth muscle cells (PASMC) and pulmonary artery endothelial cells (PAEC) and to identify whether PDGF produced in PASMC or PAEC promotes PASMC cell proliferation. We observed that the protein and mRNA expression level of both PDGFRα and PDGFRβ were upregulated in IPAH patients in comparison to normal PASMC. However, expression of PDGFRα and PDGFRβ was not detected in PAEC. PDGF treatment enhanced the activity of PDGFRα and PDGFRβ, as determined by phosphorylation of PDGFRα and PDGFRβ in IPAH PASMC compared to control. Furthermore, the PDGF‐induced rise in cytosolic free Ca2+ was also increased in IPAH PASMC in comparison to normal PASMC. Treatment with normal PAEC cultured conditioned medium enhanced PDGFRα activation in IPAH PASMC than normal PASMC, while normal PASMC cultured conditioned medium had no effect on p‐PDGFRα and p‐PDGFRβ. We further found that the expression level of PDGFA and PDGFB were increased in IPAH PAEC compare to normal PAEC. Additionally, the expression level of PDGFA and PDGFB in PAEC were increased in normoxic condition compare to hypoxia. Normal PAEC cultured conditioned medium promotes cell proliferation in PASMC; proliferation was markedly higher in IPAH PAEC cultured conditioned medium, but not in PASMC cultured conditioned medium. The data showed that the expression and activity of PDGF receptor were increased in IPAH PASMC. Overall these results suggest that IPAH PAEC secret high‐levels of PDGF to the PASMC, which can affect active PDGF receptor, promoting PASMC proliferation which can lead to pulmonary hypertension.Support or Funding InformationThis study was supported in part by the grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health (HL135807 and HL125208), the National Natural Science Foundation of China (81630004, 81470246, 81220108001 and 81520108001), the Guangzhou Department of Education Yangcheng Scholarship (12A001S), the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme of China, China Scholarship Council (201608440324) and the Actelion ENTELLIGENCE Young Investigator Award.This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Effect of IL‐17 on pulmonary artery smooth muscle cells and connective tissue disease‐associated pulmonary arterial hypertension

Systemic Evaluation of Platelet and Leukocyte Activation and Interaction in A Rat Model of Pulmonary Arterial Hypertension

IL-17A is Elevated in Patients with Chronic Obstructive Pulmonary Disease and Contributes to Airway Remodeling by Acting on Fibroblasts

Pulmonary artery smooth muscle cell pyroptosis promotes the proliferation of PASMCs by paracrine IL‑1β and IL‑18 in monocrotaline‑induced pulmonary arterial hypertensive rats

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) activates p38 to affect pulmonary fibrosis

Cysteine-rich 61 (cyr61) Upregulated in Pulmonary Arterial Hypertension Promotes the Proliferation of Pulmonary Artery Smooth Muscle Cells

Il-17a is Elevated in Patients with Copd and Contributes to Airway Remodeling by Acting on Fibroblasts

Increased Cyr61 in pulmonary arterial hypertension involving in proliferation of pulmonary arterial smooth muscle cells

Interleukin-17A Promotes Airway Remodeling in Chronic Obstructive Pulmonary Disease by Activating C-X-C Motif Chemokine Ligand 12 Secreted by Lung Fibroblasts

Interleukin-17A Promotes Aortic Endothelial Cell Activation Via Transcriptionally and Post-translationally Activating P38 Mitogen-activated Protein Kinase (MAPK) Pathway.

The role of immune cells in the pathogenesis of connective tissue diseases-associated pulmonary arterial hypertension

IL-17 Promotes p38 MAPK-Dependent Endothelial Activation Enhancing Neutrophil Recruitment to Sites of Inflammation

Endothelial‐dependent Activation of Smooth Muscle PDGF Receptors Enhances PASMC Proliferation in IPAH

The Changes and Significance of Interleukin-17 in Rat Models of Chronic Obstructive Pulmonary Disease and Asthma

Interleukin-17A plays a key role in pulmonary fibrosis following Propionibacterium acnes-induced sarcoidosis-like inflammation

IL-17A Promotes the Migration, Invasion and the EMT Process of Lung Cancer Accompanied by NLRP3 Activation

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension

IL‐17 stimulates the expression of CCL2 in cardiac myocytes via Act1/TRAF6/p38MAPK‐dependent AP‐1 activation

Protective effects of progesterone on pulmonary artery smooth muscle cells stimulated with Interleukin 6 via blocking the shuttling and transcriptional function of STAT3.

IL-17 Induces Myocardial Fibrosis and Enhances RANKL/OPG and MMP/TIMP Signaling in Isoproterenol-Induced Heart Failure.

Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension